BMRN

#862
BioMarin Pharmaceuticals Inc
55.27 USD
-0.36%
Sektor: Gesundheitswesen
Basis: USD
Gewinnwährung: USD
Tagesspanne
55.27
55.27
Jahresspanne
50.76
66.28
Tagesänderung
-0.36%
Monatliche Änderung
-2.47%
6 month change
+4.11%
Jahresänderung
-7.58%
Vorheriger Schlusskurs
55.47
Eröffnung
55.27
Bid
Ask
Tief
55.27
High
55.27
Volumen
149
Vollständige Grafik anzeigen

Financials

Übersicht Finanzbericht Statistik
Vierteljährlich Jährlich
Gewinn- und Verlustrechnung Bilanz Cashflow
Wert Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

BioMarin Pharmaceutical Inc

BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research are in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria. Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials.

Nachrichten